Ipca Laboratories

• Azelnidipine in patients with Essential Hypertension

  Phase 4, Status unknown, 108 people, 31 Aug 2026

• A real world study to evaluate safety and effectiveness of Topical Esmolol in chroic Diabetic Foot Ulcer Healing

  Phase 4, Status unknown, 750 people, 7 Aug 2026

• NCT01603134

  Phase 1, Completed, 32 people, 22 May 2012

Sources: trialsearch.who.int

• Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial

  Consulting or advice, Fees or honoraria, Grants or research support, 13 Aug 2026

Sources: pubmed.ncbi.nlm.nih.gov